“We’re Sorry We Got Caught”…

…is what McKinsey & Company and others will never say when it comes to business ethics.

This past December, McKinsey & Company, one of the world's most influential management consulting firms, agreed to pay USD650 million to settle a federal investigation into its involvement in the opioid crisis. The settlement addresses the firm’s role in advising Purdue Pharma on strategies that significantly boosted the sales of OxyContin, a powerful and highly addictive painkiller. The case serves as a stark example of how ethical lapses in business practices can contribute to widespread harm, highlighting the importance of corporate responsibility, transparency, and ethical decision-making in modern business [1,2].

McKinsey, a global consulting giant, is known for providing strategic guidance to major corporations, governments, and organizations. However, its role in the opioid epidemic paints a troubling picture of how business advice can have devastating consequences. According to investigations by the U.S. Justice Department, McKinsey worked closely with Purdue Pharma to accelerate OxyContin sales, even as evidence emerged about the drug’s addictive properties. The firm’s consultants devised strategies to increase prescriptions of OxyContin, targeting doctors who were prescribing large quantities of the drug, while minimizing the risks of addiction. Internal communications revealed that McKinsey actively helped Purdue create and execute a marketing plan to expand the reach of OxyContin, often disregarding the ethical concerns raised by the drug’s potential for abuse.

From an ethical standpoint, McKinsey’s actions raise serious questions about its commitment to corporate responsibility. Business ethics, at its core, requires companies to act in ways that are not only legal but also morally sound, ensuring that their activities do not harm society. In this case, McKinsey’s consulting services arguably prioritized earnings for Purdue Pharma over the public good, contributing to the opioid epidemic that has claimed hundreds of thousands of lives in the United States. The firm’s role in enhancing OxyContin’s sales strategy, despite knowledge of the drug’s addictive nature, illustrates a failure to adhere to basic ethical principles.

This settlement is significant not only because of the financial penalty but also because it forces McKinsey to confront its ethical failures. While the firm has apologized, the payout is an acknowledgment of the damage caused by its actions. The funds will be used to support opioid addiction treatment and recovery programs, providing some measure of restitution to the communities most affected by the crisis. The firm’s reputation for providing objective, expert advice is forever tainted by its involvement in promoting a product that has caused immense harm.

This case leaves behind important lessons about the ethical responsibilities of business leaders in shaping the future of today’s corporate practices. Companies have an obligation to their shareholders, but that shouldn’t exclude social and moral responsibilities. In the end, McKinsey-Purdue is about more than just legal settlements or financial penalties. It’s a wake-up call to think carefully about business ethics. For consulting firms in particular, both large and small, integrity, transparency, and accountability need to be at the center of every decision.

Want to learn more about addressing ethics in your business? Reach out for an initial consultation today.